Pictet-TR Aquila aims to achieve long-term capital growth with low correlation to equity markets by avoiding heavily macro dependent companies and focussing on key sectors such as Healthcare, TMT and Consumer. The fund will invest in liquid companies primarily in the US and Europe.
This strategy is being offered externally for the first time. It has been led, and managed internally from London for several years, by Asim Nurmohamed who is supported by Alexandre Diogo and Bharat Garg.
“We are delighted to be launching the Pictet TR-Aquila fund after the Aquila team has successfully managed the strategy inside of our multi-strategy funds since 2018.”
The highly experienced team members have strong research backgrounds and will draw on Pictet Asset Management’s global infrastructure and investment resources.
“We are delighted to be launching the Pictet TR-Aquila fund after the Aquila team has successfully managed the strategy inside of our multi-strategy funds since 2018. We believe this is a unique strategy within the UCITS landscape and one that will provide diversification to investor portfolios”, said Doc Horn, Head of Total Return Equities.
The fund is registered for sale in Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland and United Kingdom.
This is the tenth fund to be launched as part of Pictet Asset Management’s Total Return fund range, which now has a combined AUM of USD 9.5 billion as at 30th June 2020. It joins the market neutral funds, Agora (European equities), Akari (Japanese equities) and Diversified Alpha (multi-strategy).
Also in the range are the equity long/short directional funds, Corto (European equities), Mandarin (Greater China equities), Atlas (global equities) as well as the Distressed and Special Situations (event driven), Kosmos (global fixed income) and Sirius (EMD long/short).
Pictet Group Corporate Communications
+44 20 7847 5412